Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603135.pdf
Reference26 articles.
1. Blackledge G (2003) Cancer drugs: the next 10 years. Eur J Cancer 39: 273
2. Blackledge G, Averbuch S (2004) Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors. Br J Cancer 90: 566–572
3. Chung BI, Malkowicz SB, Nguyen TB, Libertino JA, McGarvey TW (2003) Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol 22: 533–540
4. Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146 (Suppl 61): 1–6
5. Druker BJ (2004) Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91: 1–30
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications;British Journal of Cancer;2024-06-17
2. Revolutionizing non‐melanoma skin cancer treatment: Receptor tyrosine kinase inhibitors take the stage;Journal of Cosmetic Dermatology;2024-05-29
3. Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma;iScience;2023-06
4. Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?;International Journal of Molecular Sciences;2023-03-26
5. Novel Targets in Development for Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3